Massive study tests if insurance records can mimic Gold-Standard diabetes research
NCT ID NCT07417631
First seen Feb 28, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study looks at health insurance claims from about 30,000 people with type 2 diabetes to see if they can get the same results as a famous clinical trial called REWIND. The goal is not to test a new drug, but to learn whether real-world data can be trusted to answer important medical questions. Researchers will compare two diabetes drugs, dulaglutide and sitagliptin, and track heart attacks, strokes, and deaths.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.